Display Settings:

Format

Send to:

Choose Destination
    Pediatr Infect Dis J. 2006 Apr;25(4):368-70.

    Safety and immunogenicity of live varicella virus vaccine in children with human immunodeficiency virus type 1.

    Source

    Division of General Pediatrics, Childrens Hospital Los Angeles, University of Southern California, USA.

    Abstract

    Live varicella virus vaccine was administered to 10 stable human immunodeficiency virus type 1 (HIV-1)-infected children. Subjects were monitored for adverse reactions, HIV-1 plasma levels, CD4 T cell counts and immune responses. The vaccine was well-tolerated. Varicella-zoster virus-specific lymphocyte proliferative responses were detected in all subjects by 4 weeks and in 9 of 10 subjects 1 year after vaccination.

    PMID:
    16567993
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk